📣 VC round data is live. Check it out!
- Public Comps
- Goodwill Pharma
Goodwill Pharma Valuation Multiples
Discover revenue and EBITDA valuation multiples for Goodwill Pharma and similar public comparables like MediClin, Monash IVF Group, Clinica Las Condes, Athens Medical Centre and more.
Goodwill Pharma Overview
About Goodwill Pharma
Goodwill Pharma Nyrt is a full service pharma partner for the CEE region. The company s core activities include pharmaceutical logistics and distribution, pharmaceutical registration, full pharmaceutical marketing services, medical promotion, manufacturer and brand representation, own-licensed product development, manufacturing and marketing of proprietary pharmaceuticals and dietary supplements.
Founded
N/A
HQ

Employees
N/A
Website
Sectors
Financials (FY)
EV
$226M
Valuation Multiples
Start free trialGoodwill Pharma Financials
Goodwill Pharma reported last fiscal year revenue of $75M and EBITDA of $20M.
In the same fiscal year, Goodwill Pharma generated $32M in gross profit, $20M in EBITDA, and $8M in net income.
Goodwill Pharma P&L
In the most recent fiscal year, Goodwill Pharma reported revenue of $75M and EBITDA of $20M.
Goodwill Pharma is profitable as of last fiscal year, with gross margin of 43%, EBITDA margin of 27%, and net margin of 11%.
Financial data powered by Morningstar, Inc.
Goodwill Pharma Stock Performance
Goodwill Pharma has current market cap of $209M, and enterprise value of $226M.
Market Cap Evolution
Goodwill Pharma's stock price is $1.95.
Goodwill Pharma share price increased by 5.3% in the last 30 days.
Goodwill Pharma has an EPS (earnings per share) of $0.08.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $226M | $209M | 5.3% | 5.3% | 3.0% | - | $0.08 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialGoodwill Pharma Valuation Multiples
Goodwill Pharma trades at 3.0x EV/Revenue multiple, and 11.2x EV/EBITDA.
Goodwill Pharma Financial Valuation Multiples
As of June 2, 2026, Goodwill Pharma has market cap of $209M and EV of $226M.
Goodwill Pharma has a P/E ratio of 25.7x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Goodwill Pharma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Goodwill Pharma Margins & Growth Rates
In the most recent fiscal year, Goodwill Pharma reported gross margin of 43%, EBITDA margin of 27%, and net margin of 11%.
Goodwill Pharma Margins
Goodwill Pharma Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Goodwill Pharma Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Goodwill Pharma Competitors
Goodwill Pharma competitors include MediClin, Monash IVF Group, Clinica Las Condes, Athens Medical Centre, Atrys Health, Limes Schlosskliniken, Suraksha Diagnostics, Hyperfine, Centrum Medyczne ENEL-MED and Humana.
Most Goodwill Pharma public comparables operate across Hospitals & Clinics.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.5x | 0.5x | 3.7x | 3.5x | |||
| 1.7x | 1.8x | 7.4x | 8.0x | |||
| 2.7x | - | (5.9x) | - | |||
| 1.1x | - | 11.0x | - | |||
| 2.8x | 2.7x | 19.4x | 17.6x | |||
| 2.7x | 2.5x | 10.9x | 9.6x | |||
| 5.1x | 5.3x | 15.9x | 17.0x | |||
| 9.1x | 7.6x | (3.5x) | (3.7x) | |||
This data is available for Pro users. Sign up to see all Goodwill Pharma competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Goodwill Pharma
| Where is Goodwill Pharma headquartered? | Goodwill Pharma is headquartered in Hungary. |
| Is Goodwill Pharma publicly listed? | Yes, Goodwill Pharma is a public company listed on Budapest Stock Exchange. |
| What is the stock symbol of Goodwill Pharma? | Goodwill Pharma trades under GOODWILLPHRM ticker. |
| When did Goodwill Pharma go public? | Goodwill Pharma went public in 2022. |
| Who are competitors of Goodwill Pharma? | Goodwill Pharma main competitors include MediClin, Monash IVF Group, Clinica Las Condes, Athens Medical Centre, Atrys Health, Limes Schlosskliniken, Suraksha Diagnostics, Hyperfine, Centrum Medyczne ENEL-MED, Humana. |
| What is the current market cap of Goodwill Pharma? | Goodwill Pharma's current market cap is $209M. |
| What is the current revenue of Goodwill Pharma? | Goodwill Pharma's last fiscal year revenue is $75M. |
| What is the current EV/Revenue multiple of Goodwill Pharma? | Current revenue multiple of Goodwill Pharma is 3.0x. |
| Is Goodwill Pharma profitable? | No, Goodwill Pharma is not profitable. |
| How many companies Goodwill Pharma has acquired to date? | Goodwill Pharma hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Goodwill Pharma has invested to date? | Goodwill Pharma hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Goodwill Pharma
Lists including Goodwill Pharma
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.